Draft, not yet released. In stewardship review. Not indexed until the first approved release.

Methodology

How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.

13 min read0 figures13 tables17 notesNR-XTECH-NEURO-GLOBAL-2026-BASELINE

Contents
  1. ·Edition home
  2. ·Executive summary
  3. 1Neurotechnology is clinical hardware and a new class of personal data
  4. 2Key findings
  5. 3Systems and sectors at baseline
  6. 4Risks and capability
  7. 5Consumer neural data outside medical rules
  8. 6Readings from the other desks
  9. 7The 2027 agenda
  10. 8Systems in depth
  11. AMethodology
    1. A.1 Methods
    2. A.2 Model card, Neurotechnology System Model v0
    3. A.3 The baseline evidence cut
    4. A.4 Evidence age and coverage
    5. A.5 Evidence cards, two anchor sources
    6. A.6 Publication acceptance record
    7. A.7 Status words
    8. A.8 How the edition is made, released and corrected
    9. A.9 Glossary and abbreviations
    10. A.10 Technical annex
  12. BData appendix
  13. CReferences and record
  14. ·Complete edition, for print

A.1Methods

The global baseline uses published values and four simple derivations. Each is shown in full so that any reader can reproduce it.

Table A.1Methods
No.DerivationCalculationResult
(1)Ratio of median rate in2 to rate in178 ÷ 62about 1.3 times
(2)Gap between1 and natural conversation as stated in1160 ÷ 62about 2.6 times
(3)Months from preprint to journal version of the accuracy study3December 2023 to August 20248 months
(4)Share of the 2025 round in the reported pre-money valuation20650 ÷ 9,000about 7%
Table A.2Coupling strength scale (matrix and model card)
StrengthDefinition
STRONGa disruption in the source system has historically changed the target system’s service or output within one season, in more than one region
MODERATEan effect is documented but buffered or slower
WEAKan effect is plausible but not documented at global scale
Table A.3Status grammar
LabelRule
Reportedvalue as issued by its source, with year
Inferredreasoned from cited evidence; never a measurement
EstimatedNexus analytical value with stated method
Scenarioconditional on stated assumptions
Expert inputstructured editorial judgement awaiting evidence

A.2Model card, Neurotechnology System Model v0

Model ID
MDL-XT20-NEURO · v0.1
Purpose
represent neurotechnology as clinical hardware and a source of neural data coupled to health, materials, finance, workforce and privacy
Family
graph-based system of systems
Inputs
the cited sources of this edition; no proprietary data
Method
expert-specified coupling strengths (STRONG · MODERATE · WEAK) from assessments and analogue events
Validation
none yet, first validation against federation evidence in 2027
Uncertainty
qualitative; strengths are hypotheses, not measurements
Domain of validity
global scale; not for asset-, site- or country-level use
Reproducibility
strength table and sources published in this edition
20couplings

typed in v0

0strong

documented within one season

0moderate

documented, buffered

20weak

plausible, undocumented

A.3The baseline evidence cut

Every Nexus edition is published from a frozen evidence cut. The global baseline cut is documentary: it pins the exact edition of every source cited. Federation cuts begin with the first national Foundry cuts in 2027.

Cut ID
DC-XTECH-NEURO-GLOBAL-2026-B0
Type
baseline documentary cut
Resolution policy
pinned · as of 30 September 2026
Sources pinned
44 cited sources, each at the edition and access date in the references
Model runs
none at baseline, analytical values are stated with their method
Digest
computed at freeze and recorded in the publication record
Supersedes
nothing, first cut of the series
Superseded by
the 2027 neurotechnology annual cut

Lineage

  1. 01

    source edition

  2. 02

    pinned citation

  3. 03

    finding

  4. 04

    page

  5. 05

    publication record

Table A.4From the baseline cut to the federation cut
ElementBaseline 20262027 global annual
Sourcescited global publications, pinned by editionnational, regional and sector cuts through one graph
Analysisstated methods and editorial estimatestyped analysis specifications
ModelsNeurotechnology System Model v0 specificationmodel runs with receipts
Findingstwelve baseline findingsfindings re-bound to federation evidence
Reviewfive passes scheduledfive passes on the exact digest

A.4Evidence age and coverage

A 2026 global edition rests on evidence observed in many different years. This page shows each time base, so that no single year label hides older evidence.

Table A.5Evidence age and coverage
IndicatorObservedReleasedCadenceNext release
Speech decoding papers2023Aug 2023one-offfollow-up papers
Speech accuracy over time2023 preprint · 2024 journalDec 2023 · Aug 2024one-offmore participants
Brain-spine interface2023May 2023one-offlonger follow-up
Endovascular study2025Sep 2025one-offpeer-reviewed version
PRIME registry entry2026Jan 2026continuousnext update
US neural data bill2025Sep 2025per sessioncommittee action
UNESCO Recommendation2025Nov 2025one-offnational uptake
Chinese implementation opinion2025Jul 2025periodic2027 milestones
Table A.6Coverage by system at baseline
SystemCoverageThinnest dimension
HardwarePARTIALfailure rates on a common basis
ClinicPARTIALoutcomes beyond one year
Neural dataPARTIALconsumer practices
GovernancePARTIALtext of national laws
InvestmentTHINmarket size and public funding
Energy and heatTHINpower and heat budgets
SkillsTHINworkforce numbers
MaterialsTHINdependence by platform
Table A.7Designed empty states: what is not bound, what would fill it and why
FieldSource that would fill itBlocker
Power and heat budgets of implanted interfacesdevice makers, regulators, peer-reviewed engineering papersno figure retrieved; the search for heating and power limits returned no quantitative source
Market size on a common definitionindustry statistics and audited company reports29trade sources give widely different figures by definition; none was opened
Clinical workforce for implantation, programming and follow-upnational statistics, professional bodiesnot retrieved; capability rung stays LISTED
Long-term failure and explant rates across platformstrial reports, registries, manufacturersonly one-year results read78; no common reporting
Number of participants implanted per companycompany reports and registry updates132026company statement of 5 in June 2025; a January 2026 report of 21 is secondhand and unverified
Peer-reviewed results for company-announced devicesjournals for each company claim1527company releases only; no paper located
Consumer neural data practices by companyregulators, advocacy and academic audits33report not opened; no figure used
Text of California, Montana and Connecticut neural data lawsstate legislature sites2541California page returned an access error; the others not retrieved
Public funding totals for neurotechnology programmesministries, research councilsthe national research programme budget page returned an access error
Electrode materials and fabrication dependence by platformindustry and trade statisticsonly a 2018 materials roadmap abstract read23
Status of the MIND Act after referral to committeecongressional recordstatus read from bill text and a release only
Reimbursement and access to implants by countryhealth ministries, insurersnot reviewed
Wearable and non-invasive interface deployment datacompanies, regulatorsone paper named from memory32; no figure used
Capability rungs beyond guidance and planningagencies, hospitals, laboratoriesnot reviewed

A.5Evidence cards, two anchor sources

Published in Nature 620 (2023) by a Stanford-led group. One-off study. Role: binds INF-001 and the speech tiles. Coverage: one participant with ALS and four intracortical arrays.

EVD-XT20-001

A high-performance speech neuroprosthesis1

Introduced in the US Senate in 2025 as S. 2925. One-off text. Role: binds GOV-009. Coverage: US federal study of neural data; status was committee referral.

EVD-XT20-002

MIND Act of 2025 bill text11

Table A.8Quality dimensions at baseline
DimensionEVD-XT20-001EVD-XT20-002
Completenessone participant; 50-word and 125,000-word vocabulariesfull bill text; later status not read
Timelinesspublished online 23 August 2023introduced 2025
Revisionsingle paper versionamendments possible in committee
Method transparencymethods and data in the papertext public
External validationpeer reviewlegislative process

Evidence cards to follow in 2027

  • Willett et al.1: replication in more participants
  • Chetty et al.8: peer-reviewed version
  • MIND Act11: committee action
  • Registry entry13: updated enrolment

A.6Publication acceptance record

Editorial self-check at evidence close. Every applicable item carries a disposition; the remaining items are review, approval and deposit.

Table A.9Publication acceptance record
GroupAreaItemsPassN/APending
D1Identity and scope8800
D2Source and data12912
D3Analysis and models12381
D4Findings and claims9801
D5Figures, tables, maps10622
D6Editorial and citations10802
D7Review and approval130013
D8Artefact and design12705
D9Registry and release9009

Publication gate

Conditions met
14 of 23 at evidence close
Blocking problems
none recorded
Open conditions
reviews, approval of the exact digest, deposit, registry pointer

Not applicable at baseline

Model runs
first runs in Q1 2027
Maps
plates in Q2 2027
Waivers
none

A.7Status words

Table A.10The status every value carries
StatusWhat it means
ObservedMeasured directly and published by the source.
ReportedPublished statistics of an official or institutional source.
DeclaredStated by the body concerned; not independently measured.
EstimatedA Nexus estimate from cited evidence, with its method in Annex A.
ModelledProduced by a stated model from cited inputs.
InferredReasoned from cited evidence; not measured.
ForecastA projection by the cited source.
SimulatedA simulation result under stated assumptions.
ScenarioA conditional statement under stated assumptions; never a prediction.
Expert inputExpert judgement, recorded with its basis.
CandidateProposed for a later edition; not yet evidence.
Evidence-quality levels (EQL 1 to 5) grade the source behind a value; they are not a score of the subject.

A.8How the edition is made, released and corrected

Every edition is built from a sealed evidence cut, reviewed under three keys, signed and deposited before any site shows it as published; corrections go to Nexus Standards as change proposals and feed the next cut.

StepWhat happensSource
01 Evidence arrives from the pillarsFoundry seals observations and indicator series, Universe hands over after-action and scenario findings, and contributions are screened at every gateway, including this site’s.
02 The cut is sealedOn the cut date the evidence is pinned under one identifier, so anyone can rebuild the edition from exactly what it was built on.
03 The edition is assembledThe edition is drafted from its template and content pack. Agents may draft; they never publish and never decide.
04 The keys turnAt the publisher of record the truth key comes first: every value is checked against its source or stated method before the meaning and capital keys turn. No edition moves on until every key has been turned by a named steward.
05 The gate opensA named approver releases one exact digest of the edition; any change after this point is a new version, never a silent edit.
06 Signed and depositedThe PDF, the web edition and the data bundle are signed together with a manifest and an RO-Crate description, and deposited on Zenodo with a concept and a version DOI.
07 Published on its desk’s siteOnly then does the edition show as published on its desk’s Reports site, and the Collection lists it as a part.
08 Corrections go to StandardsMethod and correction findings go to Nexus Standards as change proposals; citations, corrections and new contributions feed the next evidence cut.

A teaching model of the process, not a forecast and not a record of any run; dates and counts on this page come from the programme record. Sources: Reports governance at GCRI Canada (2026); Zenodo, repository of record for Reports deposits (2026).

Lifecycle, one state at a time: Draft, Computed, Evidence bound, Reviewed, Approved for release, Published, Corrected, Superseded. This edition is a draft.

A.9Glossary and abbreviations

Table A.11Series terms
TermMeaning
Baseline Editionthe inaugural annual edition that fixes the reference state for the series
WEFH+Bwater, energy, food, health and biodiversity, the national nexus core
Couplinga typed dependency through which one system transmits to another
Protection gapthe share of losses not covered by insurance
Capability ladderLISTED → EXISTS → ADEQUATE → TESTED → DEMONSTRATED
EQLevidence-quality level, 1–5
Evidence cuta frozen resolution of exact sources and versions
NNC · NLC · NWGNational Nexus Consortium · National Leadership Council · National Working Groups
Table A.12Abbreviations used in this edition
AbbreviationExpansion
ALSamyotrophic lateral sclerosis
BCIbrain-computer interface
DBSdeep brain stimulation
EFSearly feasibility study
FDAUS Food and Drug Administration
FTCUS Federal Trade Commission
IDEinvestigational device exemption
MINDManagement of Individuals Neural Data
MIITMinistry of Industry and Information Technology of China
PRIMEPrecise Robotically Implanted Brain-Computer Interface study
UNESCOUnited Nations Educational, Scientific and Cultural Organization
WERword error rate

A.10Technical annex

Table A.13Technical annex
ItemAnnexContentsStatus
A.1Indicator definitionsthe global indicator set, with units and sourcesIN THIS EDITION
A.2Coupling strengthsthe twenty-cell matrix and its rationaleIN THIS EDITION
A.3Scenario specificationSCN-XT20-NDT-01 assumptions and signpostsIN THIS EDITION
A.4Capability placementsrung evidence for fifteen functionsIN THIS EDITION
A.5Model diagnosticsfirst runs and validation2027
A.6Sensitivity analysesinfluence of coupling strengths2027
A.7Cluster notescards for the major clinical interface clusters2027
A.8Review statementspass-by-pass review recordAT RELEASE

A.1 · indicator definition: word error rate

Construct
share of decoded words that differ from the words the participant intended to say
Unit
percent
Method
attempted speech decoded by a trained model from implanted electrode signals, scored against the intended sentences
Source
Nature 620 (2023)12
Uncertainty
as reported by the authors; not restated here
Known limits
one participant per study; sentences and vocabulary set by the researchers

Notes

Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references

  1. 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  2. 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  3. 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
  4. 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
  5. 29UNVERIFIED, not opened: market-research reports on the neurotechnology and brain-computer interface markets for 2025 (several firms; figures differ by a large factor depending on definition), taken from search-result summaries; weak evidence and no figure used. Observation year 2025. Accessed 2026-11-03.back
  6. 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  7. 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
  8. 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
  9. 26UNVERIFIED, not opened: report of January 2026 that Neuralink was enrolling 21 participants worldwide, taken from a search-result summary of a secondhand news item citing people familiar with the matter; weak evidence. Observation year 2026. Accessed 2026-11-03.back
  10. 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
  11. 27UNVERIFIED, not opened: Paradromics (ed.), company statements on an FDA investigational device exemption for the Connect-One early feasibility study (November 2025, two initial participants) and a first implant at a university hospital, taken from search-result summaries of vendor announcements; weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-03.back
  12. 33UNVERIFIED, not opened: Neurorights Foundation (ed.), report on privacy practices of consumer neurotechnology companies, 2024, cited from memory without figures; the foundation page returned not found. Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-03.back
  13. 25UNVERIFIED, not opened: California Senate Bill 1223 (Becker), consumer privacy: sensitive personal information: neural data, signed 27 September 2024, in force 1 January 2025, taken from search-result summaries; the legislature page returned an access error. California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-03.back
  14. 41UNVERIFIED, not opened: Montana and Connecticut state laws on neural data, named in the Senate release [12] and in search-result summaries; texts not opened. State legislatures, Helena and Hartford. Observation year 2025. Accessed 2026-11-03.back
  15. 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
  16. 32UNVERIFIED, not opened: Meta Reality Labs research team, paper on a wrist-worn electromyography interface for generic human-computer interaction, Nature 2025, cited from memory; the Nature page redirected to an access check. Springer Nature, London. Observation year 2025. Accessed 2026-11-03.back
  17. 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back

Cite this annex

Valadbaygi, S. (Ed.). (2026). Annex A: Methodology. In Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces (Baseline Edition 2026, Report No. NR-XTECH-NEURO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI).

Every citation form of the whole report, BibTeX and RIS included, is on the edition home. Cite this report

ReportsContribute

Send evidence or a correction on Neurotechnology and Human–Machine Interfaces.

Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the Global Centre for Risk and Innovation (GCRI) Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.

GCRI Systems Evidence deskExponential Technology

CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.

The Global Centre for Risk and Innovation

Science · evidence · measurement

Not for profit

Our articles, maps and twins are free to read and free to republish. Readers and partners keep it that way.

Partner with us

Who funds us

GCRI is a not-for-profit institution. To ask who funds a piece of work, use the funding questions form.

Independence

Editors and the expert reviewers named on each article decide what we publish. Funders and partners do not review or approve articles before publication.

Licence

Articles: CC BY 4.0. Figures, maps, twins and data: CC BY 4.0. Other uses: ask through the permissions form.